How Dhiraj Kumar Akula is advancing scalable, real-time, and governance-driven data ecosystems across complex industries ...
Nicholas Robinson, professor of business ethics at Eastern, gave a presentation at Buzzard Hall on Thursday on how to more ...
Poster Presentation Title: Real World Clinical Experience from ENABLE, the First Phase 4 Observational Study for Patients with Relapsing Multiple Sclerosis Initiating Ublituximab BRIUMVI is a novel ...
Abstract: Accurately selecting the proper data presentation tool based on the type of data being used is one of the most essential steps toward developing a robust and effective data communication ...
Objective To examine the overall incidence rate and trends in emergency department (ED) presentations related to asthma and allergic diseases in regional Australia with a particular focus on First ...
Twelve-month data from the VOLT-AF Global IDE study found that the Volt PFA System had an industry-leading success rate (84.2%) of freedom from documented rhythm recurrence among all competitive PFA ...
Jeramie Bizzle is a web producer for CBS Chicago. Jeramie began working with CBS Chicago as an intern in 2017 and returned as a full-time Web Producer in 2021. He has previously written for the Austin ...
As a qualitative researcher, Ruth Abrams, a senior lecturer at the University of Surrey, doesn’t usually share her data. “It feels like a private moment between the researcher and the participant,” ...
Introduction The importance of conducting qualitative research alongside clinical trials of complex healthcare interventions is well established. There are various ways in which these two ...
Written feedback from FDA pre-NDA meeting includes a recommendation to conduct a second Phase 3 trial to generate additional efficacy and safety data prior to NDA submission of brilaroxazine for the ...
NEW HAVEN, Conn., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today ...